Clinical Trials

NCT06120283 | RECRUITING | PHASE1
399 participants

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2023-12-01
Completion:
2028-11-30
Conditions
  • Advanced Solid Tumor
  • Advanced Breast Cancer
  • Metastatic Breast Cancer
  • Hormone-receptor-positive Breast Cancer
  • Hormone Receptor Positive Breast Carcinoma
  • Hormone Receptor Positive Malignant Neoplasm of Breast
  • HER2-negative Breast Cancer
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Non-small Cell Lung Cancer
Interventions
  • DRUG
No Results Yet
NCT06058377 | RECRUITING | PHASE3
3680 participants

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2023-11-27
Completion:
2027-05-31
Conditions
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • HER2-Negative Breast Carcinoma
  • Hormone Receptor-Positive Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page